Pre-Filled Syringes Market (2nd Edition), 2014 - 2024

News provided by

Jul 21, 2014, 04:59 ET

DUBLIN, July 21, 2014 /PRNewswire/ --

Research and Markets Logo. (PRNewsFoto/PR NEWSWIRE EUROPE)

Research and Markets (http://www.researchandmarkets.com/research/vbcrsg/prefilled) has announced the addition of the "Pre-Filled Syringes Market (2nd Edition), 2014 - 2024" report to their offering.

(Logo: http://photos.prnewswire.com/prnh/20130307/600769 )

Most of the data presented in this report has been gathered by secondary research. We have also conducted interviews with experts in the area (academia, industry, medical practice and other associations) to solicit their opinions on emerging trends in the market. This is primarily useful for us to draw out our own opinion on how the market will shape up across different regions and drug segments. Where possible, the available data has been checked for accuracy from multiple sources of information.

The secondary sources of information include

- Annual reports
- Investor presentations
- SEC filings
- Industry databases
- News releases from company websites
- Government policy documents
- Other analysts' opinion reports

While the focus has been on forecasting the market over the coming ten years, the report also provides our independent view on various technological and non-commercial trends emerging in the industry. This opinion is solely based on our knowledge, research and understanding of the relevant market gathered from various secondary and primary sources of information.

Example Highlights:

1. The global prefilled syringes market is likely to grow at a compounded annual growth rate (CAGR) of 11.3% between 2013 to 2024. By 2024, we expect the market to achieve sales of around 12.4 billion prefilled syringes.
2. Vaccines, diluent and flush syringes are likely to be some of the key growth areas. The emergence of biologics will be a major growth driver; growth in the long-term will be fuelled by pipeline drugs and the rising adoption in developing markets.
3. Increasing number of suppliers now provide ready to fill/ sterile prefilled syringes, which make up more than 80% of the prefilled syringes market. The integration of prefilled syringes with advanced delivery systems such as pen and autoinjectors will aid in gaining wider adoption.
4. Developed markets of the US and EU together accounted for 80% of the prefilled syringes market in 2013. With the increasing adoption in China and rest of the world markets, this domination is likely to decline; by 2024, we expect the share of US and EU markets to slip to 60%.
5. The market is highly consolidated and is currently dominated by key global players such as Becton Dickinson, Gerresheimer, MGlas AG, SCHOTT and Nuova Ompi. Other companies, which are relatively new entrants (e.g. West Pharmaceutical Services, Unilife and Vetter Pharma) are likely to foster more innovation.
6. Many regional players, especially in China, Japan and other Asian economies, have also recently surfaced to exploit the opportunity offered by large home consumer markets.

Key Topics Covered:

1. PREFACE

2. EXECUTIVE SUMMARY

3. INTRODUCTION TO PREFILLED SYRINGES

4. GROWTH DRIVERS

5. PRODUCTS AVAILABLE IN PREFILLED SYRINGES

6. TECHNOLOGICAL DEVELOPMENT IN PREFILLED SYRINGES

7. LEADING GLOBAL PREFILLED SYRINGE MANUFACTURERS

8. REGIONAL PREFILLED SYRINGE MANUFACTURERS

9. SWOT ANALYSIS

10. LEADING REGIONAL MARKETS FOR PREFILLED SYRINGE SYSTEMS, 2014 - 2024

11. GLOBAL PREFILLED SYRINGES MARKET FORECAST, 2014 - 2024

12. INTERVIEW TRANSCRIPTS

13. CONCLUSION

14. APPENDIX 1: TABULATED DATA

15. APPENDIX 2: LIST OF COMPANIES AND ORGANISATIONS

Companies Mentioned